Human placenta hydrolyzate affects neutrophils of systemic immunity during cosmetic procedures

Cover Page

Cite item

Abstract

In cosmetology, various types of procedures acting via varying mechanisms are used, including those based on rather aggressive mode of action. Few evidences have been collected so far regarding an effect of such procedures on human skin and entire body. Aim: to determine response of neutrophil arm of systemic immunity to injected placental hydrolyzate, compare effectiveness and safety of cosmetic methods affecting quality of skin layers. There were enrolled 75 healthy women subdivided into three groups with 25 subjects in each group. Patients in Group 1 underwent a course of intramuscular injections with human placental hydrolysate; Group 2 – fractional photothermolysis of facial skin layers with erbium laser; Group 3 – fractional photothermolysis procedure pretreated with course of intramuscular injected human placental hydrolyzate. Samples of peripheral blood were collected from all patients for assessing baseline state of the immune system before interventions and on day 8, 14 and 24 after the onset. It was shown that level of neutrophil phagocytosis and neutrophil NBT-assay were most markedly changed after interventions. It was found that level of neutrophil phagocytosis and neutrophil NBT-assay were virtually decreased by 2-fold after fractional photothermolysis, but not in patients pre-treated with injected placental hydrolysate followed by fractional photothermolysis. Neutrophil phagocytosis and spontaneous neutrophil NBT-assay data in treated vs. baseline patients did not change, whereas level of induced NBT-assay was decreased, but to much lower extent compared to control group solely treated with fractional photothermolysis. Conclusions: introduction of placental hydrolyzate contributes to accelerated rehabilitation period after applying aggressive medical interventions, and prevents development of adverse events.

About the authors

Yu. V. Kudrevich

South Ural State Medical University

Author for correspondence.
Email: cyton@mail.ru

Kudrevich Yuliya V. - PhD (Medicine), Accociate Professor, Department of Dermatovenerology

454092, Chelyabinsk, Vorovsky str., 64

Phone: 7 (951) 237-77-45

Russian Federation

E. K. Kuznetsova

Orenburg State Medical University

Email: fake@neicon.ru

PhD (Medicine), Accociate Professor, Department of Dermatovenerology

Orenburg

Russian Federation

O. V. Shchipacheva

Institute of Immunology and Physiology, Ural Branch, Russian Academy of Sciences

Email: fake@neicon.ru

Postgraduate Student, Institute of Immunology and Physiology

Ekaterinburg

Russian Federation

I. I. Dolgushin

South Ural State Medical University

Email: fake@neicon.ru

PhD, MD (Medicine), Professor, Head, Department of Microbiology, Virology, Immunology and Clinical Laboratory Diagnostics

Chelyabinsk

Russian Federation

O. R. Ziganshin

South Ural State Medical University

Email: fake@neicon.ru

PhD, MD (Medicine), Professor, Head, Department of Dermatovenerology

Chelyabinsk

Russian Federation

References

  1. Диброва Е.А. Применение плацентарного препарата Лаеннек для подготовки к пластической операции и реабилитации после пластической операции. Патент на изобретение № 2599034, дата регистрации 25.10.2017 г, дата публикации 10.10 2016. [Dibrova E.A. The use of the placental preparation Laennec to prepare for plastic surgery and rehabilitation after plastic surgery. Patent for invention № 2599034, registration date 10.25.2017, publication date 10.10.2016.
  2. Bak D.-H., Na J., Choi M.J., Lee B.C., Oh C.T., Kim J.-Y. , Han H.J., Kim M.J., Kim T.H., Kim B.J. Anti-apoptotic effects of human placental hydrolysate against hepatocyte toxicity in vivo and in vitro. Int. J. Mol. Med., 2018, Vol. 42, no. 5, pp. 2569-2583.
  3. Bobé P., Dorić M., Kinsky R.G., Voisin G.A. Modulation of mouse anti-SRBC antibody response by placental extracts. Cell. Immunol., 1984, Vol. 89, no. 2, pp. 355-364.
  4. Han N.-R., Kim K.-Y., Kim M.-J., Kim M.-H., Kim H.-M., Jeong H.-J. Porcine placenta mitigates proteinenergy malnutrition-induced fatigue. Nutrition, 2013, Vol. 29, no. 11-12, pp. 1381-1387.
  5. HeoJ.H., Heo Y., Lee H.J., Kim M., Shin H.Y. Topical anti-inflammatory and anti-oxidative effects of porcine placenta extracts on 2,4-dinitrochlorobenzene-induced contact dermatitis. Altern. Med., 2018, Vol. 18, no. 1, 331. doi: 10.1186/s12906-018-2396-1.
  6. Kim Y.S., Park J.J., Sakoda Y., Zhao Y., Hisamichi K., Kaku T., Tamada K. Preventive and therapeutic potential of placental extract in contact hypersensitivity. Int. Immunopharmacol., 2010, Vol. 10, no. 10, pp. 1177-1184.
  7. Lee T.H., Park D.S., Jang J.Y., Lee I., Kim J.M., Choi G.S., Oh C.T., Kim J.Y., Han H.J., Han B.S., Joh J.W. Human Placenta hydrolysate promotes liver regeneration via activation of the cytokine/growth factor-mediated pathway and anti-oxidative effect. Biol. Pharm. Bull., 2019, Vol. 42, no. 4, pp. 607-616.
  8. Park H.-J., Shim H.S., Lee S., Hahm D.H., Lee H., Oh C.T., Han H.J., Ji H.J., Shim I.. Anti-stress effects of human placenta extract: Possible involvement of the oxidative stress system in rats. Altern. Med., 2018, Vol. 18, no. 1, 149. doi: 10.1186/s12906-018-2193-x.
  9. Park K.M., Cho T.H. Therapeutic effect of acupuncture point injection with placental extract in knee osteoarthritis. J. Integr. Med, 2017, Vol. 15, no. 2, pp. 135-141.
  10. Uren S., Boyle W. Isolation of macrophages from human placenta. J. Immunol. Methods, 1985, Vol. 78, no. 1, pp. 25-34.

Copyright (c) 2020 Kudrevich Y.V., Kuznetsova E.K., Shchipacheva O.V., Dolgushin I.I., Ziganshin O.R.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Свидетельство о регистрации СМИ ПИ № 77 - 11525 от 04.01.2002 выдано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies